
Phreesia Inc (PHR) Stock Forecast & Price Target
Phreesia Inc (PHR) Analyst Ratings
Bulls say
Phreesia is expected to continue its strong financial performance because of its integrated platform and its ability to address key challenges in healthcare delivery. Despite concerns about permission and consent for showing ads, the company has maintained high rates and has made changes to improve their authorization experience. While their top-line deceleration may impact their Rule of 40 objective, their position in the patient engagement market makes them well-positioned for growth. However, the recent slowdown and economic impacts may put their price target and rating at risk, and it is important to closely monitor financial metrics going forward.
Bears say
Phreesia is facing several headwinds that may impact its growth in the coming years, including a slowdown in subscription revenue, increasing competition in the healthcare industry, and the risk of losing clients due to evolving industry standards and technology. Additionally, the company's recent acquisition of AccessOne may prove to be challenging to integrate and may not generate expected revenue growth. These factors, along with the uncertainty around back-half Network Solutions commitments, have led to a disappointing updated revenue guidance for FY27. Despite the company's focus on improving the patient experience and operational efficiency, there are concerns about the sustainability of its pricing strategy, particularly in the face of pricing pressure from its pharmaceutical clients and the increasing shift towards telehealth services. The company's recent stock offering also raises questions about its ability to generate positive free cash flow in the near future. Overall, these risks and challenges contribute to a negative outlook on Phreesia's stock.
This aggregate rating is based on analysts' research of Phreesia Inc and is not a guaranteed prediction by Public.com or investment advice.
Phreesia Inc (PHR) Analyst Forecast & Price Prediction
Start investing in Phreesia Inc (PHR)
Order type
Buy in
Order amount
Est. shares
0 shares